A Randomized Trial of Concurrent Chemoradiotherapy versus Radiotherapy in Advanced Carcinoma of the Uterine Cervix

By Tseng C.-J.   Chang C.-T.   Lai C.-H.   Soong Y.-K.   Hong J.-H.   Tang S.G.   Hsueh S.  

Gynecologic Oncology, Vol. 66, Iss. 1, 1997-07 ,pp. : 52-58

Elsevier

Access to resources Recommend Favorite

Phase III randomized adjuvant study of tamoxifen alone versus sequential tamoxifen and anastrozole in Japanese postmenopausal women with hormone-responsive breast cancer: N-SAS BC03 study

By Aihara Tomohiko  

Breast Cancer Research and Treatment, Vol. 121, Iss. 2, 2010-06 ,pp. : 379-387

Springer Publishing Company

Access to resources Recommend Favorite

A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: A report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1

By Sawka C.A.  

Breast Cancer Research and Treatment, Vol. 44, Iss. 3, 1997-07 ,pp. : 211-215

Springer Publishing Company

Access to resources Recommend Favorite

Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen receptor-positive breast cancer patients. Very late results of the ‘gruppo di ricerca per la chemio-ormonoterapia adiuvante (GROCTA)’ 01-Trial in early breast cancer

By Boccardo Francesco  

Breast Cancer Research and Treatment, Vol. 126, Iss. 3, 2011-04 ,pp. : 653-661

Springer Publishing Company

Access to resources Recommend Favorite

Effects of toremifene versus tamoxifen on breast cancer patients: a meta-analysis

By Chi Feng  

Breast Cancer, Vol. 20, Iss. 2, 2013-04 ,pp. : 111-122

Springer Publishing Company

Access to resources Recommend Favorite